Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide

PURPOSE: The phase 3 CHIASMA OPTIMAL trial (NCT03252353) evaluated efficacy and safety of oral octreotide capsules (OOCs) in patients with acromegaly who previously demonstrated biochemical control while receiving injectable somatostatin receptor ligands (SRLs). METHODS: In this double-blind study,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Endocrinol Metab
Main Authors: Samson, Susan L, Nachtigall, Lisa B, Fleseriu, Maria, Gordon, Murray B, Bolanowski, Marek, Labadzhyan, Artak, Ur, Ehud, Molitch, Mark, Ludlam, William H, Patou, Gary, Haviv, Asi, Biermasz, Nienke, Giustina, Andrea, Trainer, Peter J, Strasburger, Christian J, Kennedy, Laurence, Melmed, Shlomo
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Online Only Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7470473/
https://ncbi.nlm.nih.gov/pubmed/32882036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgaa526
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares